Venture Capital

OutSee: £2.5 Million Seed Round Completed And Partnership With o2h Discovery

By Amit Chowdhry ● Jan 12, 2026

OutSee, an AI-enabled genomics and drug discovery company, has closed a £2.5 million seed funding round and signed a strategic agreement with o2h discovery to begin a collaborative drug discovery programme around OutSee’s lead drug target candidate.

Cast AI Surpasses $1 Billion Valuation Following Pacific Alliance Ventures Strategic Investment

By Amit Chowdhry ● Jan 12, 2026

Cast AI announced it has crossed a $1 billion valuation following a strategic investment from Pacific Alliance Ventures (PAV), the U.S.-based corporate venture arm of Shinsegae Group, as the company launched OMNI Compute, a unified compute marketplace designed to help enterprises access and operate GPU capacity across clouds and regions without making code changes.

Tench And Simone Coxe Donate $100 Million To Launch UT Austin Academic Medical Center

By Amit Chowdhry ● Jan 12, 2026

The University of Texas at Austin said it is moving forward with its planned academic medical center after receiving a $100 million gift from Austin residents Tench and Simone Coxe, one of the largest donations in the university’s history.

Allos: $5 Million Raised To Apply Causal AI Across Complex Drug Reformulation

By Amit Chowdhry ● Jan 12, 2026

Allos AI has raised $5 million in seed financing to commercialize what it calls the industry’s first “glass-box” Causal AI platform for reformulating complex generic drugs, as developers and manufacturers look for lower-risk ways to improve how established medicines are delivered and tolerated over long-term use.

Aspen Power Secures $200 Million Strategic Capital Commitment From Deutsche Bank

By Amit Chowdhry ● Jan 12, 2026

Aspen Power announced it has closed a $200 million capital raise from Deutsche Bank, bolstering the Carlyle-backed distributed generation platform’s financial capacity as it scales development of solar and storage projects across the U.S.

Nassau Global Credit: $400 Million In Commitments For New Credit Opportunities Strategy

By Amit Chowdhry ● Jan 12, 2026

Nassau Global Credit (NGC) announced the launch of a new Credit Opportunities strategy backed by capital commitments of up to $400 million from seed investors, expanding the firm’s credit-investing toolkit across the U.S. and Europe.

VelaFi: $20 Million Series B Raised To Expand Global Stablecoin Infrastructure

By Amit Chowdhry ● Jan 12, 2026

VelaFi, a stablecoin-powered financial infrastructure platform under Galactic Holdings, announced it has raised $20 million in a Series B financing to expand its regulated payments and settlement capabilities across Latin America, the U.S., and Asia.

Vibrant Therapeutics: $61 Million Closed And Han Lee Named As Co-CEO

By Amit Chowdhry ● Jan 12, 2026

Vibrant Therapeutics, a clinical-stage biotech developing “logic-gated” therapeutics designed to activate selectively in diseased tissue, announced it has raised $61 million in new financing and appointed Han Lee, Ph.D. as co-chief executive officer as the company prepares to broaden global development of its lead solid tumor program. The round brought in new investors, Pfizer Ventures and Apricot Capital, and included participation from Bayland Capital, HSG, Northern Light Venture Capital, and First Principle Venture Limited, according to the company. With the latest proceeds, Vibrant said its total capital raised now stands at $100 million.

Mirador Therapeutics: $250 Million Series B Raised And Multi-Asset Immuno-Fibrotic Pipeline Advanced

By Amit Chowdhry ● Jan 12, 2026

Mirador Therapeutics announced it is advancing multiple clinical-stage programs across Crohn’s disease, ulcerative colitis, rheumatoid arthritis, and idiopathic pulmonary fibrosis, with more than 10 clinical readouts expected by the end of 2027.

VieCure: $43 Million Raised To Expand AI-Powered Precision Cancer Care In Community Practices

By Amit Chowdhry ● Jan 12, 2026

VieCure announced it has raised $43 million to accelerate the rollout of its software platform designed to help community oncology clinics deliver precision-medicine care with greater speed and consistency.

Cytotheryx Lands Lead For $60 Million Series A And Adds Debt Financing To Expand Facilities

By Amit Chowdhry ● Jan 12, 2026

Cytotheryx, a preclinical cell therapy company developing cell-based treatments for liver disease, said it has secured a lead term sheet for a $60 million Series A round and lined up additional debt financing aimed at expanding its manufacturing and operational footprint.

DaVinci Commerce Raises Strategic Financing, Rebrands From Jivox To Expand Agentic Commerce Marketing Platform

By Amit Chowdhry ● Jan 12, 2026

DaVinci Commerce, formerly known as Jivox, announced it raised a strategic financing round to accelerate growth of its AI-native platform for “agentic commerce marketing,” a category it says blends automated commerce creative optimization with rapid activation across retail and commerce media networks.

Trybe: $30 Million Series A Raised To Expand Spa And Leisure Management Platform

By Amit Chowdhry ● Jan 12, 2026

Trybe, a provider of software for spas, bathhouses, resorts, hotels, and other leisure operators, has raised a $30 million Series A investment from Five Elms Capital as it looks to scale internationally and deepen product capabilities across payments, bookings, and operations.

Harmattan AI: $200 Million Series B Raised And Strategic Partnership With Dassault Aviation

By Amit Chowdhry ● Jan 12, 2026

Dassault Aviation and Harmattan AI announced they have formed a strategic partnership aimed at accelerating the integration of controlled autonomy and artificial intelligence into combat aviation systems, with Dassault leading a $200 million Series B financing for the defense technology company.

Arkin Capital Closes $100 Million Bio Ventures III Fund For Early-Stage Biotech Investing

By Amit Chowdhry ● Jan 12, 2026

Arkin Capital announced it has closed Arkin Bio Ventures III, a $100 million fund that will back advanced pre-clinical and early clinical-stage biotechnology companies developing therapies for high unmet medical needs.

Terra Industries Raises $11.75 Million To Scale Autonomous Security Systems For Africa’s Critical Infrastructure

By Amit Chowdhry ● Jan 12, 2026

Terra Industries, a defense technology company developing autonomous security systems to protect critical infrastructure across Africa, has emerged from stealth with an $11.75 million funding round led by U.S. venture firm 8VC.

QXO Upsizes Convertible Preferred Equity Commitment to $3 Billion

By Amit Chowdhry ● Jan 12, 2026

QXO announced it has expanded a previously announced convertible preferred equity financing to $3 billion, increasing the commitment by $1.8 billion, as it seeks additional capacity to fund future acquisitions.

Avenue Biosciences: $5.7 Million Seed Extension Raised To Scale Secretory Pathway Platform For Therapeutic Protein Manufacturing

By Amit Chowdhry ● Jan 12, 2026

Avenue Biosciences, a Palo Alto-based protein engineering technology company, has raised $5.7 million in seed extension funding to scale a high-throughput platform designed to measure and modulate the protein secretory pathway, a core cellular process responsible for folding, modifying, and secreting therapeutic proteins.

Apheon: €1.25 Billion Closed For Sixth Flagship Midcap Buyout Fund

By Amit Chowdhry ● Jan 12, 2026

Apheon Management announced it has closed its sixth flagship mid-market vehicle, Apheon MidCap Buyout VI SCSp, at the €1.25 billion hard cap, with an additional €50 million commitment from the firm’s team and related families, bringing total fund size to €1.3 billion.

Atlantic Alumina Lands $450 Million U.S.-Backed Deal To Secure Domestic Alumina Supply

By Amit Chowdhry ● Jan 12, 2026

Atlantic Alumina Company LLC (ATALCO), the only operating alumina refinery in the United States, said it has entered a $450 million strategic partnership with the U.S. Department of War and Concord Resources Holdings Limited aimed at sustaining and expanding U.S. alumina production while establishing what the company described as America’s first large-scale primary gallium production circuit.

BrowserStack Launches $125 Million ESOP And Share Buyback Program For Employees and Early Investors

By Amit Chowdhry ● Jan 12, 2026

BrowserStack announced a $125 million employee stock ownership plan (ESOP) and share buyback program that will provide liquidity to more than 500 current and former employees as well as early investors. The transaction marks the company’s third buyback and brings BrowserStack’s cumulative buyback total to more than $275 million across the three programs.

Nanochon: $4.1 Million Seed Prime II Round Raised To Advance Knee Cartilage Implant Into First-in-Human Study

By Amit Chowdhry ● Jan 12, 2026

Nanochon, a Washington, D.C.-based orthopedic device company developing an implant to treat articular cartilage defects in the knee, said it has secured commitments to close an oversubscribed $4.1 million Seed Prime II financing, bringing total capital raised to date to $11.3 million. The round was led by cultivate(MD), with participation from the University of Virginia UVA Seed Fund, WSGR, Wealthing VC Fund, and other investors. Nanochon said the majority of the financing came from existing backers, while also adding new individuals and funds to its investor base.

Guggenheim Investments Closes $250 Million New Private Debt Vehicle Backed by LGT Capital Partners

By Amit Chowdhry ● Jan 12, 2026

Guggenheim Investments said it has closed a $250 million vehicle that will invest in the firm’s private debt strategy, backing an existing portfolio of loans while supporting continued expansion of the platform. The transaction was led by LGT Capital Partners, alongside additional limited partners.

Elbit Wins $275 Million Deal To Add EW And Laser Missile Defense To Asia-Pacific Helicopters

By Amit Chowdhry ● Jan 12, 2026

Elbit Systems announced it has been awarded contracts worth about $275 million to supply an Asia-Pacific customer with an advanced airborne self-protection package for a helicopter platform, including an electronic warfare (EW) suite and the company’s Mini-MUSIC direct infrared countermeasure (DIRCM) system. The work is scheduled to be carried out over five years.

PhotonPay: Series B Closed To Pioneer Stablecoin-Centric Financial Infrastructure

By Amit Chowdhry ● Jan 11, 2026

PhotonPay announced it has raised “tens of millions of U.S. dollars” in a Series B funding round to expand what it describes as a stablecoin-native global financial infrastructure platform for cross-border payments, treasury, and embedded finance.

Cloudforce: $10 Million Series A Raised To Advance International Expansion

By Amit Chowdhry ● Jan 11, 2026

Cloudforce, a Maryland-based AI company focused on regulated industries, has closed a $10 million Series A funding round led by Owl Ventures, with strategic participation from M12, Microsoft’s venture fund. The company said the investment deepens its go-to-market alignment with Microsoft, including access to Microsoft’s enterprise sales organization and product teams, as Cloudforce expands deployment of its nebulaONE platform.

Venture Capital

OutSee: £2.5 Million Seed Round Completed And Partnership With o2h Discovery

Cast AI Surpasses $1 Billion Valuation Following Pacific Alliance Ventures Strategic Investment

Tench And Simone Coxe Donate $100 Million To Launch UT Austin Academic Medical Center

Allos: $5 Million Raised To Apply Causal AI Across Complex Drug Reformulation

Aspen Power Secures $200 Million Strategic Capital Commitment From Deutsche Bank

Nassau Global Credit: $400 Million In Commitments For New Credit Opportunities Strategy

VelaFi: $20 Million Series B Raised To Expand Global Stablecoin Infrastructure

Vibrant Therapeutics: $61 Million Closed And Han Lee Named As Co-CEO

Mirador Therapeutics: $250 Million Series B Raised And Multi-Asset Immuno-Fibrotic Pipeline Advanced

VieCure: $43 Million Raised To Expand AI-Powered Precision Cancer Care In Community Practices

Cytotheryx Lands Lead For $60 Million Series A And Adds Debt Financing To Expand Facilities

DaVinci Commerce Raises Strategic Financing, Rebrands From Jivox To Expand Agentic Commerce Marketing Platform

Trybe: $30 Million Series A Raised To Expand Spa And Leisure Management Platform

Harmattan AI: $200 Million Series B Raised And Strategic Partnership With Dassault Aviation

Arkin Capital Closes $100 Million Bio Ventures III Fund For Early-Stage Biotech Investing

Terra Industries Raises $11.75 Million To Scale Autonomous Security Systems For Africa’s Critical Infrastructure

QXO Upsizes Convertible Preferred Equity Commitment to $3 Billion

Avenue Biosciences: $5.7 Million Seed Extension Raised To Scale Secretory Pathway Platform For Therapeutic Protein Manufacturing

Apheon: €1.25 Billion Closed For Sixth Flagship Midcap Buyout Fund

Atlantic Alumina Lands $450 Million U.S.-Backed Deal To Secure Domestic Alumina Supply

BrowserStack Launches $125 Million ESOP And Share Buyback Program For Employees and Early Investors

Nanochon: $4.1 Million Seed Prime II Round Raised To Advance Knee Cartilage Implant Into First-in-Human Study

Guggenheim Investments Closes $250 Million New Private Debt Vehicle Backed by LGT Capital Partners

Elbit Wins $275 Million Deal To Add EW And Laser Missile Defense To Asia-Pacific Helicopters

PhotonPay: Series B Closed To Pioneer Stablecoin-Centric Financial Infrastructure

Cloudforce: $10 Million Series A Raised To Advance International Expansion

Idea Financial Lands $20 Million Term Loan From EverBank To Expand Small Business And Legal Lending

Eir Partners Closes Oversubscribed Fund III At $1 Billion

Ventaris Surgical: $30 Million Series A Raised To Develop Next-Generation Kidney Stone Treatment System

Platinum Equity Invests In Norton Packaging